Irinotecan Hydrochloride Liposome
(I-rih-noh-TEE-kan HY-droh-KLOR-ide LY-poh-some)
This page contains brief information about irinotecan hydrochloride liposome and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Use in Cancer
Irinotecan hydrochloride liposome is approved to be used with fluorouracil andleucovorin to treat:
- Pancreatic cancer that has metastasized (spread to other parts of the body). It is used in patients whose disease has gotten worse after treatment withgemcitabine.
Irinotecan hydrochloride liposome is also being studied in the treatment of other types of cancer.
Irinotecan hydrochloride liposome is a form of irinotecan hydrochloride contained inside liposomes (very tiny particles of fat). This form may work better than other forms of irinotecan hydrochloride and have fewer side effects. Also, because its effects last longer in the body, it doesn't need to be given as often. For more information about irinotecan hydrochloride that may apply to irinotecan hydrochloride liposome, see the Drug Information Summary for Irinotecan Hydrochloride.
More About Irinotecan Hydrochloride Liposome
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Irinotecan Hydrochloride Liposome - Check for trials from NCI's list of cancer clinical trials now accepting patients.
No hay comentarios:
Publicar un comentario